AU2023217269A1 - Process for manufacturing macrocyclic peptides - Google Patents

Process for manufacturing macrocyclic peptides Download PDF

Info

Publication number
AU2023217269A1
AU2023217269A1 AU2023217269A AU2023217269A AU2023217269A1 AU 2023217269 A1 AU2023217269 A1 AU 2023217269A1 AU 2023217269 A AU2023217269 A AU 2023217269A AU 2023217269 A AU2023217269 A AU 2023217269A AU 2023217269 A1 AU2023217269 A1 AU 2023217269A1
Authority
AU
Australia
Prior art keywords
compound
formula
fmoc
boc
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023217269A
Other languages
English (en)
Inventor
Jean-Michel Adam
Fritz Bliss
Pascal Jean Claude Dott
Fabienne Roxane HOFFMANN-EMERY
Vera JOST
Ulf Goeran LARSSON
Kurt Puentener
Georg WUITSCHIK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2023217269A1 publication Critical patent/AU2023217269A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2023217269A 2022-02-14 2023-02-13 Process for manufacturing macrocyclic peptides Pending AU2023217269A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22156480 2022-02-14
EP22156480.0 2022-02-14
PCT/EP2023/053409 WO2023152347A1 (en) 2022-02-14 2023-02-13 Process for manufacturing macrocyclic peptides

Publications (1)

Publication Number Publication Date
AU2023217269A1 true AU2023217269A1 (en) 2024-05-16

Family

ID=80683163

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023217269A Pending AU2023217269A1 (en) 2022-02-14 2023-02-13 Process for manufacturing macrocyclic peptides

Country Status (12)

Country Link
US (1) US20250109166A1 (cg-RX-API-DMAC7.html)
EP (1) EP4479396A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505521A (cg-RX-API-DMAC7.html)
KR (1) KR20240144894A (cg-RX-API-DMAC7.html)
CN (1) CN118660878A (cg-RX-API-DMAC7.html)
AR (1) AR128501A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023217269A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237617A1 (cg-RX-API-DMAC7.html)
IL (1) IL313664A (cg-RX-API-DMAC7.html)
MX (1) MX2024009210A (cg-RX-API-DMAC7.html)
TW (1) TW202342493A (cg-RX-API-DMAC7.html)
WO (1) WO2023152347A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026068674A1 (en) 2024-09-27 2026-04-02 F. Hoffmann-La Roche Ag Process for deprotection of aminoacid derivatives
WO2026093183A1 (en) 2024-10-29 2026-05-07 F. Hoffmann-La Roche Ag Process for manufacturing an antibiotic macrocyclic peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6136934B2 (ja) 2011-12-15 2017-05-31 味の素株式会社 Fmoc基の除去方法
US11819532B2 (en) * 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii

Also Published As

Publication number Publication date
AR128501A1 (es) 2024-05-15
WO2023152347A1 (en) 2023-08-17
US20250109166A1 (en) 2025-04-03
MX2024009210A (es) 2024-08-06
CN118660878A (zh) 2024-09-17
EP4479396A1 (en) 2024-12-25
JP2025505521A (ja) 2025-02-28
CA3237617A1 (en) 2023-08-17
TW202342493A (zh) 2023-11-01
IL313664A (en) 2024-08-01
KR20240144894A (ko) 2024-10-04

Similar Documents

Publication Publication Date Title
KR101467598B1 (ko) Hcv 프로테아제 억제제 중간체의 제조방법
JP5593342B2 (ja) ドセタキセルの製造方法
WO2023152347A1 (en) Process for manufacturing macrocyclic peptides
US8163937B2 (en) Process for preparing (1R,2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
WO2014145507A1 (en) A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
WO2013131978A1 (en) Process for the preparation of intermediates useful in the preparation of a viral protease inhibitor
CN114269338A (zh) 生产二氮杂螺内酰胺化合物的方法和中间体
TW202302620A (zh) 胺基酸或肽之製造方法、保護基形成用試藥及化合物
HK40111281A (en) Process for manufacturing macrocyclic peptides
JPWO2002048153A1 (ja) Gm−95物質の製法
WO2026010901A1 (en) Process for preparing lipidated peptide and its intermediates
KR100194158B1 (ko) 1-(d-3-아세틸티오-2-메틸프로파노일)-l-프롤린-l-페닐알라닌의 제조방법
HK40111936A (en) Method for producing compound or pharmaceutically acceptable salt thereof
SU1133272A1 (ru) Ди- @ -оксисукцинимидный эфир щавелевой кислоты в качестве реагента дл синтеза @ -оксисукцинимидных эфиров @ -защищенных аминокислот
CN118165067A (zh) 一种Frag A和其中间体的制备方法
CZ296780B6 (cs) Zpusob prípravy amidu
EP4545523A1 (en) Preparation process for jaktinib dihydrochloride monohydrate
HK1133261B (en) Process for preparing (1r,2s,5s)-n-[(1s)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
HK1108317B (en) Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
HK1140490B (en) Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ ADAM, JEAN-MICHEL; BLISS, FRITZ; DOTT, PASCAL JEAN CLAUDE; HOFFMANN-EMERY, FABIENNE ROXANE; LARSSON, ULF GOERAN; PUENTENER, KURT; WUITSCHIK, GEORG AND JOST, VERA